Several factors must be considered in support of extended monitoring: clinical conditions, such as renal failure, vitamin D deficiency, diabetes, and obesity, may require a prolongation of monitoring with an increase in the number of samples, either by modifying the kinetics of PTH or for other causes29–32. This evidence concerns the gene PTH and vitamin D deficiency.